empanelment of drug testing laboratories - Kerala Medical Services ...

More documents

Recommendations

Info

DETAILS OF LABORATORY Name of the Laboratory : Full Address : Registration details : Place of business : Phone No : Fax : E-mail : Branches & their Address : Date of Inspection : License No. & Date : Issued by : Valid up to : Details of testing activity : Clients List : Name of the authorized signatory : Specimen Signature of the authorized Signatory : Specimen Signature of the officer who is authorized to sign the test reports : ANNEXURE-VII Ref. Clause No.5.10.18 ANNEXURE-VIII KMSCL: EOI for Empanelment of Drug testing Laboratories Page 45
CONSENT LETTER OF THE OFFERER From, Name of the Laboratory, Address of the Laboratory To, The EOI Inviting Authority Sir, Subject-Consent for testing of Drugs/Items Reference-KMSCL/QC/EOI/FY12-14/02 Ref. Clause No.5.10.19 With reference to your EOI document, we here by submit our consent to test the following items of drugs at the rates specified in Annexure-VIII and as per the conditions stipulated in the EOI documents referred above. Sl.No. Drug Code Name of the Drug with specifications Rate S/d (Name of the Offerer) KMSCL: EOI for Empanelment of Drug testing Laboratories Page 46
Page 1 and 2: KERALA MEDICAL SERVICES CORPORATION
Page 3 and 4: SECTION I INTRODUCTION 1.1. The Ker
Page 5 and 6: SECTION - II INVITATION OF EXPRESSI
Page 7 and 8: 2.16. The EOI Responder must submit
Page 9 and 10: 4.1 Time Limits Prescribed: SECTION
Page 11 and 12: 5.1 Contents of the EOI Document: S
Page 13 and 14: 5.4.10 A prospective offerer requir
Page 15 and 16: 5.7.4 It is also an opportunity for
Page 17 and 18: 5.10.17 Declaration in the Proforma
Page 19 and 20: opening of the envelopes before the
Page 21 and 22: 5.17.7 The availability of technica
Page 23 and 24: 5.22 Notification of Award/Letter o
Page 25 and 26: 5.24.6 Corporation will release the
Page 27 and 28: egard shall be in writing and the C
Page 29 and 30: testing fees at artificial non-comp
Page 31 and 32: 5.33.1 Nothing contained in this Co
Page 33 and 34: ANNEXURES KMSCL: EOI for Empanelmen
Page 35 and 36: EOI Cost EMD 12. Annexure VII - Det
Page 37 and 38: No.4.2.8 (Provide contact details l
Page 39 and 40: ANNEXURE- II (b) Ref. Clause No.5.1
Page 41 and 42: ANNEXURE-III Ref. Clause No.5.10.3
Page 43 and 44: PROFORMA FOR PERFORMANCE STATEMENT
Page 45: DECLARATION FORM ANNEXURE-VI Ref. C
Page 49 and 50: liability under this guarantee and
Page 51 and 52: And whereas the Laboratory has depo
Page 53 and 54: which bank details shall be furnish
Page 55 and 56: 14. In the event of any disputes be
Page 57 and 58: 39 D04017 Bupivacaine In Dextrose I
Page 59 and 60: 101 D18007/ Electrolyte P(Multi Inj
Page 61 and 62: 160 D02025 Metronidazole IP. Inj 5
Page 63 and 64: 228 D03001 Theophylline and Etophyl
Page 65 and 66: 40 S27050 Endotracheal Tube 5.0 1 U
Page 67 and 68: 19 S27004 Hypo Allergic Acrylic Pap
Page 69 and 70: 25 S27572 26 S27531 27 S27574 28 S2
Page 71 and 72: DETAILS OF LABRATES FOR THE DRUGS A
Page 73 and 74: 45 D11006 Cabergoline tab Tab 0.5mg
Page 75 and 76: 88 D01028 Diclofenac sodium Gel Gel
Page 77 and 78: 126 D02074 Hpylori kit Each combi p
Page 79 and 80: 163 D04026 Lignocaine topical Spray
Page 81 and 82: 207 D24052 Octreotide Inj Inj 50 mc
Page 83 and 84: 255 D08028 Pyrantel Palmoate Syrup
Page 85: 302 D20037 Ursodeoxycholic Acid Tab

empanelment of drug testing laboratories - Kerala Medical Services ...

Create successful ePaper yourself

Delete template?

Save as template?